COMP <GO>
MLAB vs TMO // FORWARD P/E MULTIPLE
Mesa Laboratories Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MLAB 2
— TMO 9
▲ FORWARD P/E MULTIPLE LEADER: TMO
LAST: $133.03 (+1.30%) • MKT CAP: $744.4M
forward-pe
103.1x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLAB VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MLAB | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 9.30% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.6x | 30.4x | +3.20 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 5.32% | 2.40% | +2.92 | MLAB | /fcf-yield <GO> |
| Operating Margin | 7.40% | 17.40% | -10.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.70% | 15.10% | -12.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.40% | 3.90% | -0.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.47% | 0.24% | +0.23 | MLAB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.07 | 4.50 | -2.43 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 62.9 | -13.94 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 103.1x | 36.3x | +66.80 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $744.4M | $262.22B | -$261.47B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MLAB REV | TMO REV | MLAB GROSS % | TMO GROSS % | MLAB FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $249.1M | $44.56B | 63.5% | — | $39.6M | $6.29B |
| FY 2024 | $241.0M | $42.88B | 62.6% | — | $42.6M | $7.27B |
| FY 2023 | $216.2M | $42.86B | — | — | $44.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLAB // BETA —
TMO // BETA 0.94